Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs etomidate-propofol anesthesia in elderly breast cancer mastectomy
ChiCTR2500106237Phase 4Not yet recruiting
- Sponsor
- Huainan First People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in breast cancer (2 arms), sponsored by Huainan First People's Hospital. Primary endpoints: Postoperative pain, Cognitive function and 1 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2500106237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106237.